Ryan Sobel, MD
Obstetrics & Gynecology · Philadelphia, PANPI 1962477174
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,843 of the $15,526 with a category attached, or 69.8%. Biomerieux Inc accounts for 64.7% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $10,067, 8.9 times the $1,128 reported in 2020. Among obstetrics & gynecology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $862.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomerieux Inc$10K
- Scynexis, Inc.$3K
- Organon$2K
- Lupin Inc.$1K
- Coopersurgical, Inc.$36
- Hologic Sales And Service, LLC$15
- plus $13 from 1 others
Across 8 payments — averaging $5266.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Scynexis, Inc.$42K
What the payments were for
- Consulting fees$10,84370%
- Speaking & faculty fees$2,95019%
- Travel & lodging$1,0207%
- Food & beverage$7135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomerieux Inc | 7 | $10,038 |
| Scynexis, Inc. | 5 | $2,634 |
| Organon | 2 | $1,660 |
| Lupin Inc. | 1 | $1,128 |
| Coopersurgical, Inc. | 1 | $36 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Qiagen, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLOSEC$1,128
How this compares
$15,526 in reported general payments places this provider in the 95th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 304 | $26,778 |
| YuvafemEstradiol | 52 | $9,915 |
| Clobetasol Propionate | 143 | $7,897 |
| PremarinEstrogens, Conjugated | 19 | $6,795 |
| Fluconazole | 133 | $1,796 |
| Clindamycin Phosphate | 17 | $1,298 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 19 | $1,196 |
| Estradiol (Once Weekly)Estradiol | 11 | $1,172 |
| ValacyclovirValacyclovir Hcl | 28 | $875 |
| Amitriptyline Hcl | 15 | $636 |
| Gabapentin | 21 | $597 |
| Nortriptyline Hcl | 18 | $488 |
| Metronidazole | 19 | $413 |
| Ketoconazole | 24 | $370 |
| Triamcinolone Acetonide | 21 | $302 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Philadelphia
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Jamille Nagtalon-RamosPhiladelphia$183K
- Matthew BesharaPhiladelphia$56K
- Karolynn EcholsPhiladelphia$38K
- Miriam RaffeldPhiladelphia$33K
- Dana ShanisPhiladelphia$33K
- Alex SorianoPhiladelphia$22K
- Dacarla AlbrightPhiladelphia$20K
- Rupsa BoeligPhiladelphia$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.